<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Acute hydrocarbon exposure: Management</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Acute hydrocarbon exposure: Management</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Acute hydrocarbon exposure: Management</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Authors:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Alfred Aleguas, Jr, BS Pharm, PharmD, DABAT, FAACT</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">William J Lewander, MD</a></dd><dt><span> </span>Section Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Michele M Burns, MD, MPH</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Michael Ganetsky, MD</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Jun 01, 2022.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H3355981616"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>This topic will discuss the management of acute hydrocarbon toxicity. Clinical toxicity, evaluation, and diagnosis of acute hydrocarbon exposure and inhalant abuse in children and adolescents are discussed separately. (See  <a class="medical medical_review" href="/d/html/6489.html" rel="external">"Acute hydrocarbon exposure: Clinical toxicity, evaluation, and diagnosis"</a> and  <a class="medical medical_review" href="/d/html/6502.html" rel="external">"Inhalant misuse in children and adolescents"</a>.)</p><p class="headingAnchor" id="H774832528"><span class="h1">STABILIZATION</span><span class="headingEndMark"> — </span>Most hydrocarbon exposures involve ingestion of a small amount of an aliphatic or terpene hydrocarbon and are stable at presentation. However, patients with large ingestions, asphyxial inhalation exposure, or exposure to aromatic or halogenated hydrocarbons may require emergency stabilization of the airway, breathing, and circulation as follows [<a href="#rid1">1</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Severe respiratory distress</strong> <strong>or altered mental status</strong> – Patients with severe respiratory distress, those who are unresponsive to oxygen and beta-2 bronchodilators (eg, <a class="drug drug_general" data-topicid="9396" href="/d/drug information/9396.html" rel="external">albuterol</a>), or those with significant lethargy or coma that makes them unable to maintain their airway should undergo endotracheal intubation. (See  <a class="medical medical_review" href="/d/html/270.html" rel="external">"Rapid sequence intubation in adults for emergency medicine and critical care"</a> and  <a class="medical medical_review" href="/d/html/6390.html" rel="external">"Rapid sequence intubation (RSI) in children for emergency medicine: Approach"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Cardiac arrhythmias</strong> – All symptomatic patients and asymptomatic patients who have ingested aromatic or halogenated hydrocarbons warrant a 12-lead electrocardiogram and continuous cardiac monitoring for ventricular arrhythmias. Patients with ventricular arrhythmias should receive Pediatric or Advanced Cardiac Life Support that is modified by avoiding the use of <a class="drug drug_general" data-topicid="9409" href="/d/drug information/9409.html" rel="external">epinephrine</a>. (See <a class="local">'Ventricular arrhythmias'</a> below.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Seizures</strong> – Patients with seizures should receive benzodiazepines (eg, <a class="drug drug_general" data-topicid="9573" href="/d/drug information/9573.html" rel="external">lorazepam</a> or <a class="drug drug_general" data-topicid="9345" href="/d/drug information/9345.html" rel="external">diazepam</a>) in addition to support of airway and breathing to improve oxygenation. (See  <a class="medical medical_review" href="/d/html/2217.html" rel="external">"Convulsive status epilepticus in adults: Classification, clinical features, and diagnosis"</a> and  <a class="medical medical_review" href="/d/html/6192.html" rel="external">"Management of convulsive status epilepticus in children"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Organophosphate exposure from co-ingestion</strong> – Patients with suspected organophosphate exposure indicated by muscarinic findings (eg, salivation, miosis, lacrimation, urination, bronchorrhea, vomiting, and/or diarrhea), seizures, and/or nicotinic findings (diaphoresis, muscle fasciculations, and weakness) warrant presumptive antidotal treatment with <a class="drug drug_general" data-topicid="8983" href="/d/drug information/8983.html" rel="external">atropine</a> and <a class="drug drug_general" data-topicid="9802" href="/d/drug information/9802.html" rel="external">pralidoxime</a> as described in the rapid overview table  (<a class="graphic graphic_table graphicRef63540" href="/d/graphic/63540.html" rel="external">table 1</a>) and discussed in detail separately. (See  <a class="medical medical_review" href="/d/html/339.html" rel="external">"Organophosphate and carbamate poisoning", section on 'Management'</a>.)</p><p></p><p class="headingAnchor" id="H3494432548"><span class="h1">MANAGEMENT</span><span class="headingEndMark"> — </span>Successful management of hydrocarbon exposure requires recognition of pulmonary, cardiac, and/or neurologic toxicity and rapid initiation of appropriate supportive care.</p><p>Regional poison control centers in the United States are available at all times for consultation on patients who are critically ill, require admission, or have clinical pictures that are unclear (1-800-222-1222). In addition, some hospitals have clinical and/or medical toxicologists available for bedside consultation and/or inpatient care. Whenever available, these are invaluable resources to help in the diagnosis and management of toxic exposures. Contact information for poison centers around the world is provided separately. (See  <a class="medical medical_society_guidelines" href="/d/html/138307.html" rel="external">"Society guideline links: Regional poison control centers"</a>.)</p><p class="headingAnchor" id="H87364183"><span class="h2">Staff protection</span><span class="headingEndMark"> — </span>Prior to initiating decontamination of patients with external hydrocarbon exposure, the health care team should don personal protective equipment appropriate to the hazard posed by the specific chemical. (See  <a class="medical medical_review" href="/d/html/345.html" rel="external">"Topical chemical burns: Initial evaluation and management", section on 'Protection of clinicians'</a>.)</p><p class="headingAnchor" id="H3519638033"><span class="h2">External decontamination</span><span class="headingEndMark"> — </span>Contaminated clothing should be removed from the patient to prevent continued inhalation exposure. Affected skin and hair should also be cleansed as many hydrocarbons cause irritation [<a href="#rid2">2</a>].</p><p>Certain hydrocarbon compounds (eg, gasoline, methylene chloride) cause cell membrane injury and dissolution of lipids, which may result in skin necrosis and burns with prolonged exposure. Treatment of dermal and ocular exposure initially consists of pain control and copious water irrigation.</p><p>External decontamination should not delay life-saving interventions (eg, endotracheal intubation for respiratory failure or coma, treatment of arrhythmias, or anticonvulsant therapy). (See  <a class="medical medical_review" href="/d/html/345.html" rel="external">"Topical chemical burns: Initial evaluation and management", section on 'Hydrocarbons'</a>.)</p><p class="headingAnchor" id="H3723851399"><span class="h2">Hydrocarbon ingestion</span></p><p class="headingAnchor" id="H2024510541"><span class="h3">Gastrointestinal decontamination</span><span class="headingEndMark"> — </span>The approach to gastrointestinal decontamination after hydrocarbon ingestion varies according to the type and amount of hydrocarbon ingestion:</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Isolated petroleum distillate or terpene hydrocarbon ingestion</strong> – Most patients with an isolated aliphatic or terpene hydrocarbon ingestion should <strong>not </strong>receive activated charcoal or undergo gastric emptying because of the risk of provoking vomiting and further pulmonary aspiration  (<a class="graphic graphic_algorithm graphicRef129167" href="/d/graphic/129167.html" rel="external">algorithm 1</a>) [<a href="#rid1">1-4</a>]. Furthermore, activated charcoal does not bind well to hydrocarbons and is unlikely to be beneficial.</p><p></p><p class="bulletIndent1">Some experts suggest nasogastric aspiration in patients who ingest large amounts of aliphatic hydrocarbons (eg, suicide attempt in an adult patient) and present within 60 minutes because of the potential for systemic absorption with central nervous system (CNS) and pulmonary toxicity [<a href="#rid3">3</a>]. Consultation with a regional poison control center is strongly advised when determining the need to provide gastrointestinal decontamination procedures in such patients. (See <a class="local">'Additional resources'</a> below.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Aromatic or halogenated hydrocarbon ingestion</strong> – Consultation with a regional poison control center is strongly advised when determining the need to provide gastrointestinal decontamination procedures in patients who have ingested aromatic or halogenated hydrocarbons (see  <a class="medical medical_review" href="/d/html/6489.html" rel="external">"Acute hydrocarbon exposure: Clinical toxicity, evaluation, and diagnosis", section on 'Additional resources'</a>). For such patients who present for care within 60 minutes of ingestion, we suggest gastric emptying using nasogastric aspiration [<a href="#rid3">3</a>].</p><p></p><p class="bulletIndent1">This recommendation is based on clinical experience regarding how to manage this uncommon scenario and randomized trials that indicate little benefit of gastric lavage more than 60 minutes after an ingestion [<a href="#rid3">3,5,6</a>]. Nasogastric lavage should only be performed when the risk of systemic toxicity from gastrointestinal absorption of the hydrocarbon is equal to or exceeds the increased risk of pulmonary aspiration associated with nasogastric lavage. Nasogastric lavage should be withheld in patients with a depressed mental status who may not be able to protect their airway, unless endotracheal intubation is performed first. The following measures, performed before nasogastric aspiration, may minimize the risk of pulmonary toxicity:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Endotracheal intubation with a balloon-cuffed endotracheal tube</p><p class="bulletIndent2"><span class="glyph">•</span>Left lateral decubitus with mild Trendelenburg positioning (eg, head inclined 20 degrees below the feet)</p><p class="bulletIndent2"><span class="glyph">•</span>Pinching off the nasogastric tube and withdrawing it quickly after the procedure is complete</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Polysubstance ingestion</strong> – For patients who present within two hours of exposure and ingest hydrocarbons that are combined with an adsorbable toxic additive (eg, organophosphates or other pesticide/herbicide) or who co-ingest a life-threatening amount of prescription medicines or other adsorbable toxin, we suggest administration of a single dose of activated charcoal (1 g/kg) [<a href="#rid3">3,7</a>].</p><p></p><p class="bulletIndent1">The recommendation of activated charcoal administration in this select group of patients who ingest hydrocarbons derives from indirect evidence of benefit in volunteers, animal studies, and evidence of benefit following ingestions of other substances. Because of adverse effects, such as vomiting and dehydration, the combination of a cathartic (eg, <a class="drug drug_general" data-topicid="9940" href="/d/drug information/9940.html" rel="external">sorbitol</a>) and activated charcoal should be used sparingly, if at all, and only a single dose of a cathartic should be given to any patient. (See  <a class="medical medical_review" href="/d/html/321.html" rel="external">"Gastrointestinal decontamination of the poisoned patient", section on 'Evidence of efficacy and adverse effects'</a> and  <a class="medical medical_review" href="/d/html/321.html" rel="external">"Gastrointestinal decontamination of the poisoned patient", section on 'Cathartics'</a>.)</p><p></p><p class="headingAnchor" id="H1717388616"><span class="h3">Symptomatic patients</span><span class="headingEndMark"> — </span>Common symptoms after acute hydrocarbon exposure reflect lung, CNS, and/or cardiac toxicity.</p><p class="headingAnchor" id="H482287840"><span class="h4">Chemical pneumonitis</span><span class="headingEndMark"> — </span>Patients with mild to moderate respiratory symptoms on presentation are at risk for the development of significant chemical pneumonitis with progression to respiratory failure over the next 24 to 48 hours. In addition to supplemental oxygen, as needed, and close monitoring, they should have chest radiographs performed at the time of presentation  (<a class="graphic graphic_algorithm graphicRef129167" href="/d/graphic/129167.html" rel="external">algorithm 1</a>). These patients should also not have any oral intake (remain NPO) during the initial observation period and receive maintenance intravenous fluids.</p><p>The treatment of hydrocarbon pneumonitis is supportive and includes close monitoring of respiratory status [<a href="#rid1">1</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Oxygen </strong>– Patients with hypoxemia (eg, pulse oximetry &lt;90 percent) should receive oxygen therapy to maintain an oxygen saturation of at least 93 percent with a target of 96 percent. Patients who require oxygen concentrations of &gt;60 percent for longer than six hours warrant measures to avoid oxygen toxicity. (See  <a class="medical medical_review" href="/d/html/1622.html" rel="external">"Adverse effects of supplemental oxygen", section on 'Prevention'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Bronchospasm </strong>– Bronchospasm should be treated with selective beta-2 agonists.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Hypercarbic</strong> <strong>respiratory failure or CNS depression</strong> – Endotracheal intubation and conventional mechanical ventilation are indicated for hypercarbic respiratory failure or CNS depression with an inability to maintain the airway [<a href="#rid7">7,8</a>]. (See  <a class="medical medical_review" href="/d/html/109649.html" rel="external">"Initiating mechanical ventilation in children"</a> and  <a class="medical medical_review" href="/d/html/277.html" rel="external">"Mechanical ventilation of adults in the emergency department"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Respiratory failure with severe hypoxemia</strong> – Although evidence is lacking for the progressive management of severe hypoxemic respiratory failure in patients with chemical pneumonitis, it is reasonable to perform a trial of high-flow nasal cannula oxygen delivery and/or noninvasive ventilation in alert patients in an attempt to stabilize their condition and avoid endotracheal intubation and mechanical ventilation. (See  <a class="medical medical_review" href="/d/html/122550.html" rel="external">"High-flow nasal cannula oxygen therapy in children"</a> and  <a class="medical medical_review" href="/d/html/114077.html" rel="external">"Heated and humidified high-flow nasal oxygen in adults: Practical considerations and potential applications"</a> and  <a class="medical medical_review" href="/d/html/100358.html" rel="external">"Noninvasive ventilation for acute and impending respiratory failure in children"</a> and  <a class="medical medical_review" href="/d/html/126295.html" rel="external">"Noninvasive ventilation in adults with acute respiratory failure: Practical aspects of initiation"</a>.)</p><p></p><p class="bulletIndent1">For patients who receive mechanical ventilation, lung-sparing strategies are appropriate to reduce barotrauma. (See  <a class="medical medical_review" href="/d/html/109649.html" rel="external">"Initiating mechanical ventilation in children", section on 'Inadequate oxygenation'</a> and  <a class="medical medical_review" href="/d/html/1653.html" rel="external">"Acute respiratory distress syndrome: Ventilator management strategies for adults"</a>.)</p><p></p><p class="bulletIndent1">Therapeutic options for the small minority of children who have hydrocarbon pneumonitis and respiratory failure with severe hypoxemia unresponsive to conventional mechanical ventilation include:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Exogenous surfactant</strong> – Exogenous surfactant has been proposed to enhance oxygenation based upon case reports and may be appropriate to try prior to more invasive therapy [<a href="#rid9">9,10</a>]. If used, a formulation that is resistant to inactivation (eg, <a class="drug drug_general" data-topicid="8834" href="/d/drug information/8834.html" rel="external">calfactant</a>) is preferred [<a href="#rid9">9</a>].</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>High-frequency ventilation</strong> – Case reports in children also indicate that high-frequency ventilation (eg, jet ventilation, high-frequency oscillatory ventilation, or high-frequency percussion ventilation) may be lifesaving for selected patients [<a href="#rid11">11-13</a>].</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Extracorporeal membrane oxygenation (ECMO)</strong> – In a case series that evaluated survival after ECMO, 13 of 19 (68 percent) of children with hydrocarbon pneumonitis survived versus 52 percent of over 880 children with other respiratory disease [<a href="#rid14">14</a>]. This experience suggests that the pulmonary injury sustained by children with hydrocarbon pneumonitis is reversible in some patients and that ECMO may be lifesaving in selected patients with severe hydrocarbon pneumonitis.</p><p></p><p class="bulletIndent1">Advanced ventilatory strategies and therapeutic options in adults are discussed separately. (See  <a class="medical medical_review" href="/d/html/1653.html" rel="external">"Acute respiratory distress syndrome: Ventilator management strategies for adults", section on 'Refractory patients'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Parenchymal lung disease (pneumonitis and pneumatoceles)</strong> – Patients with chemical pneumonitis should <strong>not</strong> receive antibiotics unless signs of secondary infection, including the following, are present:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Recurrence of fever after the first 48 hours [<a href="#rid15">15</a>]</p><p class="bulletIndent2"><span class="glyph">•</span>Increasing infiltrate on chest radiograph</p><p class="bulletIndent2"><span class="glyph">•</span>Leukocytosis after the first 48 hours</p><p class="bulletIndent2"><span class="glyph">•</span>Sputum or tracheal aspirate positive for bacteria</p><p></p><p class="bulletIndent1">Corticosteroids have shown no beneficial effect on the course of hydrocarbon aspiration pneumonitis in observational studies and may be harmful [<a href="#rid16">16,17</a>].</p><p></p><p class="bulletIndent1">Pneumatoceles usually resolve spontaneously and do not require specific treatment [<a href="#rid18">18,19</a>].</p><p></p><p class="headingAnchor" id="H1831396277"><span class="h4">Ventricular arrhythmias</span><span class="headingEndMark"> — </span>Hydrocarbon ingestion and inhalation may sensitize the myocardium to catecholamine-induced ventricular arrhythmias, especially after inhalational exposure to halogenated hydrocarbons. Treatment depends upon the presentation:</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Ventricular arrhythmias with cardiac arrest</strong> – For patients who develop ventricular arrhythmias with cardiac arrest after inhaled hydrocarbon exposure or any exposure to halogenated hydrocarbons, we suggest modification of Advanced Cardiac Life Support or Pediatric Advanced Life Support  (<a class="graphic graphic_algorithm graphicRef129983" href="/d/graphic/129983.html" rel="external">algorithm 2</a> and <a class="graphic graphic_algorithm graphicRef129942" href="/d/graphic/129942.html" rel="external">algorithm 3</a>) treatment of ventricular fibrillation or pulseless ventricular tachycardia consisting of early administration of <a class="drug drug_general" data-topicid="9558" href="/d/drug information/9558.html" rel="external">lidocaine</a> in place of <a class="drug drug_general" data-topicid="9409" href="/d/drug information/9409.html" rel="external">epinephrine</a> [<a href="#rid20">20</a>]. Epinephrine should be <strong>avoided </strong>because it may further precipitate ventricular arrhythmias.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Unstable ventricular tachycardia</strong> – Patients with unstable ventricular tachycardia after hydrocarbon exposure should undergo synchronized cardioversion  (<a class="graphic graphic_algorithm graphicRef130747" href="/d/graphic/130747.html" rel="external">algorithm 4</a> and <a class="graphic graphic_algorithm graphicRef129940" href="/d/graphic/129940.html" rel="external">algorithm 5</a>).</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Stable ventricular tachycardia</strong> – Patients with stable ventricular tachycardia warrant pharmacologic therapy in consultation with a cardiologist.</p><p></p><p>For patients who persist with ventricular arrhythmias after inhalant use despite the use of Advanced Life Support protocols, administration of <a class="drug drug_general" data-topicid="9829" href="/d/drug information/9829.html" rel="external">propranolol</a> or <a class="drug drug_general" data-topicid="9420" href="/d/drug information/9420.html" rel="external">esmolol</a> may be beneficial [<a href="#rid20">20</a>]. (See  <a class="medical medical_review" href="/d/html/916.html" rel="external">"Catecholaminergic polymorphic ventricular tachycardia"</a>.)</p><p class="headingAnchor" id="H18832447"><span class="h4">Lethargy or coma</span><span class="headingEndMark"> — </span>In our experience, lethargy or coma typically resolves within 12 hours of exposure with supportive care alone, but patients who cannot maintain their airway require endotracheal intubation and mechanical ventilation for airway protection [<a href="#rid7">7</a>].</p><p class="headingAnchor" id="H3918418668"><span class="h4">Seizures</span><span class="headingEndMark"> — </span>Seizures should be treated with benzodiazepines (eg, <a class="drug drug_general" data-topicid="9345" href="/d/drug information/9345.html" rel="external">diazepam</a> or <a class="drug drug_general" data-topicid="9573" href="/d/drug information/9573.html" rel="external">lorazepam</a>) and aggressive treatment of hypoxemia. For patients with status epilepticus, arrhythmogenic anticonvulsants (eg, <a class="drug drug_general" data-topicid="8480" href="/d/drug information/8480.html" rel="external">fosphenytoin</a> and <a class="drug drug_general" data-topicid="9769" href="/d/drug information/9769.html" rel="external">phenytoin</a>) should be <strong>avoided</strong>. In such patients, the clinician may use <a class="drug drug_general" data-topicid="9904" href="/d/drug information/9904.html" rel="external">levetiracetam</a> or <a class="drug drug_general" data-topicid="9763" href="/d/drug information/9763.html" rel="external">phenobarbital</a> in consultation with a neurologist. (See  <a class="medical medical_review" href="/d/html/6192.html" rel="external">"Management of convulsive status epilepticus in children", section on 'Emergency antiseizure treatment'</a> and  <a class="medical medical_review" href="/d/html/96933.html" rel="external">"Convulsive status epilepticus in adults: Management", section on 'Emergency antiseizure treatment'</a>.)</p><p>Seizures occurring after a hydrocarbon exposure should also raise the concern for possible organophosphate poisoning, especially when associated with signs of cholinergic excess and/or muscle weakness  (<a class="graphic graphic_table graphicRef63540" href="/d/graphic/63540.html" rel="external">table 1</a>). (See  <a class="medical medical_review" href="/d/html/339.html" rel="external">"Organophosphate and carbamate poisoning", section on 'Management'</a>.)</p><p class="headingAnchor" id="H3821749005"><span class="h3">Asymptomatic patients</span><span class="headingEndMark"> — </span>Patients who are asymptomatic at presentation warrant serial examinations with monitoring of pulse oximetry. These patients should also not have any oral intake (remain NPO) during the initial observation period. Radiographic evaluation should occur at four to six hours after hydrocarbon ingestion or sooner if the patient becomes symptomatic (eg, increased respiratory distress or decreased oxygen saturation by pulse oximetry) or vomits  (<a class="graphic graphic_algorithm graphicRef129167" href="/d/graphic/129167.html" rel="external">algorithm 1</a>).</p><p class="headingAnchor" id="H3074147708"><span class="h3">Disposition</span><span class="headingEndMark"> — </span>The disposition after acute hydrocarbon exposure is determined by the specific hydrocarbon, presence of co-ingestants, and degree of toxicity:</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Ingestion of petroleum distillates, turpentine, and other aliphatic hydrocarbons</strong> – Clinical findings and radiographic results largely determine patient disposition after petroleum distillate, turpentine, or other aliphatic hydrocarbon ingestion  (<a class="graphic graphic_algorithm graphicRef129167" href="/d/graphic/129167.html" rel="external">algorithm 1</a>):</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Patients with early onset of respiratory distress are at significant risk of respiratory failure and warrant admission to an intensive care unit [<a href="#rid21">21,22</a>].</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Patients who develop mild signs of chemical pneumonitis during observation or have an abnormal chest radiograph warrant inpatient admission with the level of care determined by the degree of findings.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Patients who may be discharged or medically cleared for mental health evaluation after an intentional exposure include:</p><p></p><p class="bulletIndent3"><span class="glyph">-</span>Asymptomatic patients with normal chest radiographs obtained four or more hours after exposure</p><p></p><p class="bulletIndent3"><span class="glyph">-</span>Asymptomatic patients with mildly abnormal chest radiographs who do not develop symptoms or hypoxemia during the observation period and can receive timely outpatient follow-up the next day</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Pine oil ingestion</strong> – Patients with persistent lethargy at four hours after ingestion or signs of chemical pneumonitis warrant hospital admission as described above.</p><p></p><p class="bulletIndent1">Patients with rapid resolution of lethargy and without evidence of chemical pneumonitis at four to six hours after ingestion may be discharged home.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Aromatic or halogenated hydrocarbon ingestion or inhalation</strong> – Patients with an abnormal electrocardiogram, arrhythmias, or lethargy that does not resolve after four hours of observation warrant admission to an intensive care or cardiac telemetry unit.</p><p></p><p class="bulletIndent1">Patients with ingestion but without evidence of cardiac toxicity during a four- to six-hour observation period should have their disposition determined by signs of chemical pneumonitis, either respiratory symptoms or abnormal chest radiograph, as described above.</p><p></p><p class="bulletIndent1">Patients with mild symptoms that quickly resolve warrant mental health screening for substance use disorder, depression, and suicidality but may be discharged with appropriate psychiatric and other medical follow-up. (See  <a class="medical medical_review" href="/d/html/6502.html" rel="external">"Inhalant misuse in children and adolescents", section on 'Disposition'</a>.)</p><p></p><p class="headingAnchor" id="H1127288605"><span class="h2">Hydrocarbon inhalation or other exposure</span></p><p class="headingAnchor" id="H525527701"><span class="h3">Hydrocarbon inhalation</span><span class="headingEndMark"> — </span>The management of hydrocarbon inhalation is discussed in detail separately. (See  <a class="medical medical_review" href="/d/html/6502.html" rel="external">"Inhalant misuse in children and adolescents", section on 'Management'</a>.)</p><p class="headingAnchor" id="H3061576245"><span class="h3">Chemical burns</span><span class="headingEndMark"> — </span>External decontamination as described above is typically sufficient for most patients with brief dermal exposure to hydrocarbons. (See <a class="local">'External decontamination'</a> above.)</p><p>Patients with prolonged exposure can develop partial and full thickness burns due to dermal absorption. These patients should receive emergency consultation with a burn specialist. Initial management of these chemical burns is described separately. (See  <a class="medical medical_review" href="/d/html/345.html" rel="external">"Topical chemical burns: Initial evaluation and management"</a>.)</p><p>In addition, patients with partial or full thickness burns can develop systemic toxicity that, depending upon the specific chemical compound and degree of exposure, can rarely cause severe pulmonary, neurologic, cardiac, hepatic, and/or renal toxicity [<a href="#rid23">23</a>].</p><p>The disposition for patients with hydrocarbon chemical burns is determined by the extent and depth of the burn as discussed separately. (See  <a class="medical medical_review" href="/d/html/6567.html" rel="external">"Moderate and severe thermal burns in children: Emergency management"</a> and  <a class="medical medical_review" href="/d/html/350.html" rel="external">"Emergency care of moderate and severe thermal burns in adults"</a>.)</p><p class="headingAnchor" id="H1402862979"><span class="h3">Intentional parenteral injection</span><span class="headingEndMark"> — </span>Parenteral injection of hydrocarbons can cause major tissue destruction including tissue necrosis and necrotizing fasciitis. These patients warrant emergency surgical consultation and hospital admission.</p><p>Initial treatment of subcutaneous or intramuscular injection consists of elevation and immobilization of the affected extremity [<a href="#rid24">24</a>]. These patients should be admitted to a surgical service for frequent assessment of neurovascular status and compartment syndrome.</p><p>Indications for surgical intervention include [<a href="#rid24">24</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>Neurovascular compromise</p><p class="bulletIndent1"><span class="glyph">●</span>Elevated compartment pressure</p><p class="bulletIndent1"><span class="glyph">●</span>Development of an abscess</p><p class="bulletIndent1"><span class="glyph">●</span>Persistent fever, increased leukocytosis, worsening pain, and signs of tissue ischemia</p><p></p><p class="bulletIndent1">For patients who have injected radiopaque hydrocarbons (eg, chlorinated hydrocarbons) and have developed necrotizing fasciitis, radiographs of the extremity can help identify the surgical margins for debridement.</p><p></p><p>In addition to localized tissue effects, intravenous injection can cause thrombophlebitis and hemorrhagic pneumonitis with hypoxemic respiratory failure. These patients require supportive intensive care similar to patients with severe chemical pneumonitis. (See <a class="local">'Chemical pneumonitis'</a> above.)</p><p class="headingAnchor" id="H1404109160"><span class="h3">High-pressure paint injection</span><span class="headingEndMark"> — </span>High-pressure paint injection injuries are deceptive because the extent of chemical contamination is usually much greater than what is initially apparent on inspection [<a href="#rid25">25</a>]. They typically involve the nondominant hand or finger [<a href="#rid26">26</a>]. Hydrocarbon-based paints have the highest potential for tissue necrosis, but latex- and water-based paints can cause similar damage.</p><p>Initial treatment consists of tetanus prophylaxis, prophylactic antibiotics targeting skin pathogens (including methicillin-resistant <em>Staphylococcus aureus</em> in regions with high prevalence), and emergency consultation with a hand surgeon [<a href="#rid26">26</a>]. These injuries typically require emergency debridement under regional or general anesthesia. Hydrocarbon injection is associated with a higher risk for widespread tissue necrosis that requires amputation.</p><p class="headingAnchor" id="H1186948998"><span class="h2">Co-ingestion of organophosphate pesticides</span><span class="headingEndMark"> — </span>Treatment of organophosphate poisoning is provided in the table  (<a class="graphic graphic_table graphicRef63540" href="/d/graphic/63540.html" rel="external">table 1</a>) and discussed in detail separately. (See  <a class="medical medical_review" href="/d/html/339.html" rel="external">"Organophosphate and carbamate poisoning"</a>.)</p><p class="headingAnchor" id="H4197402313"><span class="h1">PROGNOSIS</span><span class="headingEndMark"> — </span>Most patients have mild or no serious clinical toxicity after acute hydrocarbon exposure [<a href="#rid27">27</a>]. The typical clinical course of chemical pneumonitis ranges from two to five days. The mild central nervous system (CNS) depression that is seen soon after ingestion seldom produces serious morbidity provided that further pulmonary aspiration does not occur. Rarely, patients with chemical pneumonitis may progress rapidly to respiratory failure and death. CNS effects (eg, somnolence, convulsions, and coma) and/or pulmonary symptoms may dominate the course.</p><p>Evidence is lacking to suggest long-term clinically important pulmonary effects from hydrocarbon aspiration [<a href="#rid28">28</a>].</p><p class="headingAnchor" id="H157823731"><span class="h1">PREVENTION</span><span class="headingEndMark"> — </span>Legislation that requires child-resistant packaging and education to keep hydrocarbons in their original containers have been the primary means of preventing hydrocarbon exposure [<a href="#rid29">29</a>]. By contrast, product engineering to adjust viscosity and surface tension of lamp oil in the European Union was unsuccessful in reducing the number or severity of hydrocarbon aspiration exposures [<a href="#rid30">30</a>].</p><p>The prevention of poisoning in children is discussed in detail separately. (See  <a class="medical medical_review" href="/d/html/2873.html" rel="external">"Prevention of poisoning in children"</a>.)</p><p class="headingAnchor" id="H4032272331"><span class="h1">ADDITIONAL RESOURCES</span></p><p class="headingAnchor" id="H1508333138"><span class="h2">Regional poison control centers</span><span class="headingEndMark"> — </span>Regional poison control centers in the United States are available at all times for consultation on patients with known or suspected poisoning, and who may be critically ill, require admission, or have clinical pictures that are unclear (1-800-222-1222). In addition, some hospitals have medical toxicologists available for bedside consultation. Whenever available, these are invaluable resources to help in the diagnosis and management of ingestions or overdoses. Contact information for poison centers around the world is provided separately. (See  <a class="medical medical_society_guidelines" href="/d/html/138307.html" rel="external">"Society guideline links: Regional poison control centers"</a>.)</p><p class="headingAnchor" id="H3094960991"><span class="h2">Society guideline links</span><span class="headingEndMark"> — </span>Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See  <a class="medical medical_society_guidelines" href="/d/html/112689.html" rel="external">"Society guideline links: General measures for acute poisoning treatment"</a> and  <a class="medical medical_society_guidelines" href="/d/html/114014.html" rel="external">"Society guideline links: Treatment of acute poisoning caused by specific agents other than drugs of abuse"</a>.)</p><p class="headingAnchor" id="H1587039770"><span class="h1">SUMMARY AND RECOMMENDATIONS</span></p><p class="bulletIndent1"><span class="glyph">●</span>Regional poison control centers in the United States are available at all times for consultation on patients who are critically ill, require admission, or have clinical pictures that are unclear (1-800-222-1222). In addition, some hospitals have clinical and/or medical toxicologists available for bedside consultation and/or inpatient care. Whenever available, these are invaluable resources to help in the diagnosis and management of toxic exposures. Contact information for poison centers around the world is provided separately. (See <a class="local">'Management'</a> above and <a class="local">'Additional resources'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Prior to initiating decontamination of patients with external hydrocarbon exposure, the health care team should don personal protective equipment appropriate to the hazard posed by the specific chemical. (See <a class="local">'Staff protection'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Contaminated clothing should be removed from the patient to prevent continued inhalation exposure. Affected skin and hair should also be cleansed as many hydrocarbons cause irritation. Prolonged exposure to certain compounds (eg, gasoline or methylene chloride) may also cause skin necrosis and burns. Treatment of dermal and ocular exposure initially consists of pain control and copious water irrigation. (See <a class="local">'External decontamination'</a> above and  <a class="medical medical_review" href="/d/html/345.html" rel="external">"Topical chemical burns: Initial evaluation and management", section on 'Hydrocarbons'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Most patients with an isolated aliphatic or terpene hydrocarbon ingestion should <strong>not </strong>receive activated charcoal or undergo gastric emptying because of the risk of provoking vomiting and further pulmonary aspiration. Consultation with a regional poison control center is advised to determine the benefit for nasogastric aspiration or administration of activated charcoal in selected patients (see <a class="local">'Gastrointestinal decontamination'</a> above): </p><p></p><p class="bulletIndent2"><span class="glyph">•</span>For patients with an ingestion of a large amount of an aliphatic hydrocarbon (eg, suicide attempt in an adult patient), aromatic hydrocarbon, or halogenated hydrocarbon who present within 60 minutes of ingestion, we suggest nasogastric aspiration (<a class="grade" href="https://medilib.ir/uptodate/show/grade_6" rel="external">Grade 2C</a>).</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>For patients with hydrocarbon ingestion and co-ingestion of a life-threatening agent with potential for adsorption with activated charcoal who present within two hours of ingestion, we suggest a single dose of activated charcoal (<a class="grade" href="https://medilib.ir/uptodate/show/grade_6" rel="external">Grade 2C</a>). </p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Supportive care is the primary treatment for symptomatic chemical pneumonitis  (<a class="graphic graphic_algorithm graphicRef129167" href="/d/graphic/129167.html" rel="external">algorithm 1</a>):</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Chemical pneumonitis is treated with supplemental oxygen as needed, selective beta-2 agonists (eg, <a class="drug drug_general" data-topicid="9396" href="/d/drug information/9396.html" rel="external">albuterol</a>) for bronchospasm, and high-flow nasal cannula oxygen delivery or noninvasive/invasive mechanical ventilation for respiratory failure with severe hypoxemia. Potential advanced therapies for children failing conventional mechanical ventilation include exogenous surfactant (eg, <a class="drug drug_general" data-topicid="8834" href="/d/drug information/8834.html" rel="external">calfactant</a>), high-frequency ventilation, and extracorporeal membrane oxygenation (ECMO). (See <a class="local">'Chemical pneumonitis'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Patients with chemical pneumonitis should <strong>not</strong> receive antibiotics unless signs of secondary infection are present. Corticosteroids are potentially harmful and should be avoided. (See <a class="local">'Chemical pneumonitis'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Hydrocarbon ingestion and inhalation sensitizes the myocardium to catecholamine-induced ventricular arrhythmias. We suggest that patients who develop ventricular arrhythmias with cardiac arrest after hydrocarbon exposure receive Advanced Cardiac Life Support or Pediatric Advanced Life Support modified to include early administration of <a class="drug drug_general" data-topicid="9558" href="/d/drug information/9558.html" rel="external">lidocaine</a> in place of <a class="drug drug_general" data-topicid="9409" href="/d/drug information/9409.html" rel="external">epinephrine</a> (<a class="grade" href="https://medilib.ir/uptodate/show/grade_6" rel="external">Grade 2C</a>). Epinephrine should be <strong>avoided </strong>because it may further precipitate ventricular arrhythmias  (<a class="graphic graphic_algorithm graphicRef129983" href="/d/graphic/129983.html" rel="external">algorithm 2</a> and <a class="graphic graphic_algorithm graphicRef129942" href="/d/graphic/129942.html" rel="external">algorithm 3</a>). For patients who persist with ventricular arrhythmias after inhalant use despite the use of Advanced Life Support protocols, administration of <a class="drug drug_general" data-topicid="9829" href="/d/drug information/9829.html" rel="external">propranolol</a> or <a class="drug drug_general" data-topicid="9420" href="/d/drug information/9420.html" rel="external">esmolol</a> may be beneficial. (See <a class="local">'Ventricular arrhythmias'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Lethargy or coma typically resolves within 12 hours of exposure with supportive care alone, but patients who cannot maintain their airway require endotracheal intubation and mechanical ventilation for airway protection.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Seizures should be treated with benzodiazepines (eg, <a class="drug drug_general" data-topicid="9345" href="/d/drug information/9345.html" rel="external">diazepam</a> or <a class="drug drug_general" data-topicid="9573" href="/d/drug information/9573.html" rel="external">lorazepam</a>) and aggressive treatment of hypoxemia. For patients with status epilepticus, arrhythmogenic anticonvulsants (eg, <a class="drug drug_general" data-topicid="8480" href="/d/drug information/8480.html" rel="external">fosphenytoin</a> and <a class="drug drug_general" data-topicid="9769" href="/d/drug information/9769.html" rel="external">phenytoin</a>) should be <strong>avoided</strong>. In such patients, the clinician may use <a class="drug drug_general" data-topicid="9904" href="/d/drug information/9904.html" rel="external">levetiracetam</a> or <a class="drug drug_general" data-topicid="9763" href="/d/drug information/9763.html" rel="external">phenobarbital</a>; consultation with a neurologist is warranted.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Patients who are asymptomatic after hydrocarbon ingestion warrant serial examinations with monitoring of pulse oximetry. These patients should also not have any oral intake (remain NPO) during the initial observation period. Radiographic evaluation should occur at four to six hours  (<a class="graphic graphic_algorithm graphicRef129167" href="/d/graphic/129167.html" rel="external">algorithm 1</a>).</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Clinical findings and radiographic results largely determine patient disposition after petroleum distillate, turpentine, or other aliphatic hydrocarbon ingestion. (See <a class="local">'Disposition'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Management of other types of hydrocarbon exposures include:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>External decontamination as described above is typically sufficient for most patients with brief dermal exposure to hydrocarbons (see <a class="local">'External decontamination'</a> above). Patients with prolonged exposure can develop partial and full thickness burns due to dermal absorption. These patients should receive emergency consultation with a burn specialist. Initial management of these chemical burns is described separately. (See  <a class="medical medical_review" href="/d/html/345.html" rel="external">"Topical chemical burns: Initial evaluation and management"</a>.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Parenteral injection of hydrocarbons can cause major tissue destruction including tissue necrosis and necrotizing fasciitis. These patients warrant emergency surgical consultation and hospital admission. (See <a class="local">'Intentional parenteral injection'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>High-pressure paint injection injuries are deceptive because the extent of chemical contamination is usually much greater than what is initially apparent on inspection. Initial treatment consists of tetanus prophylaxis, prophylactic antibiotics targeting skin pathogens (including methicillin-resistant <em>S. aureus</em> in regions with high prevalence), and emergency consultation with a hand surgeon. (See <a class="local">'High-pressure paint injection'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Hydrocarbon inhalation is discussed in detail separately. (See  <a class="medical medical_review" href="/d/html/6502.html" rel="external">"Inhalant misuse in children and adolescents", section on 'Management'</a>.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Treatment of organophosphate poisoning is provided in the table  (<a class="graphic graphic_table graphicRef63540" href="/d/graphic/63540.html" rel="external">table 1</a>) and discussed in detail separately. (See  <a class="medical medical_review" href="/d/html/339.html" rel="external">"Organophosphate and carbamate poisoning"</a>.)</p></div><div class="headingAnchor" id="references"><ol id="reference"><li><a class="nounderline abstract_t">Tormoehlen LM, Tekulve KJ, Nañagas KA. Hydrocarbon toxicity: A review. Clin Toxicol (Phila) 2014; 52:479.</a></li><li><a class="nounderline abstract_t">Arena JM. Hydrocarbon poisoning--current management. Pediatr Ann 1987; 16:879.</a></li><li class="breakAll">Riggan MAA, Gummin DD. Hydrocarbons. In: Goldfrank's Toxicologic Emergencies, 11th edition, Nelson LS, Howland MA, Lewin NA, Smith SW, Goldfrank LR, Hoffman RS (Eds), McGraw-Hill, New York 2019. p.1409.</li><li><a class="nounderline abstract_t">Shannon M. Ingestion of toxic substances by children. N Engl J Med 2000; 342:186.</a></li><li><a class="nounderline abstract_t">Vale JA, Kulig K, American Academy of Clinical Toxicology, European Association of Poisons Centres and Clinical Toxicologists. Position paper: gastric lavage. J Toxicol Clin Toxicol 2004; 42:933.</a></li><li><a class="nounderline abstract_t">Benson BE, Hoppu K, Troutman WG, et al. Position paper update: gastric lavage for gastrointestinal decontamination. Clin Toxicol (Phila) 2013; 51:140.</a></li><li class="breakAll">Lewander WJ, Aleguas A. Petroleum distillates and plant hydrocarbons. In: Haddad and Winchester's Clinical Management of Poisoning and Drug Overdose, 4th, Shannon MW, Borron SW, Burns MJ (Eds), Saunders Elsevier, Philadelphia 2007. p.1343.</li><li><a class="nounderline abstract_t">Zucker AR, Berger S, Wood LD. Management of kerosene-induced pulmonary injury. Crit Care Med 1986; 14:303.</a></li><li><a class="nounderline abstract_t">Sommer C, Johnson AB, Sam Wang G, Poel K. Surfactant for the management of pediatric hydrocarbon ingestion. Am J Emerg Med 2018; 36:2260.</a></li><li><a class="nounderline abstract_t">Mastropietro CW, Valentine K. Early administration of intratracheal surfactant (calfactant) after hydrocarbon aspiration. Pediatrics 2011; 127:e1600.</a></li><li><a class="nounderline abstract_t">Bysani GK, Rucoba RJ, Noah ZL. Treatment of hydrocarbon pneumonitis. High frequency jet ventilation as an alternative to extracorporeal membrane oxygenation. Chest 1994; 106:300.</a></li><li><a class="nounderline abstract_t">Mabe TG, Honeycutt T, Cairns BA, et al. High-frequency percussive ventilation in a pediatric patient with hydrocarbon aspiration. Pediatr Crit Care Med 2007; 8:383.</a></li><li><a class="nounderline abstract_t">Lee LK, Shannon MS, Arnold JH. The use of high frequency oscillatory ventilation in hydrocarbon pneumonitis. Int J Med Toxicol 2003; 6:10.</a></li><li><a class="nounderline abstract_t">Chyka PA. Benefits of extracorporeal membrane oxygenation for hydrocarbon pneumonitis. J Toxicol Clin Toxicol 1996; 34:357.</a></li><li><a class="nounderline abstract_t">Karlson KH Jr. Hydrocarbon poisoning in children. South Med J 1982; 75:839.</a></li><li><a class="nounderline abstract_t">Marks MI, Chicoine L, Legere G, Hillman E. Adrenocorticosteroid treatment of hydrocarbon pneumonia in children--a cooperative study. J Pediatr 1972; 81:366.</a></li><li><a class="nounderline abstract_t">Steele RW, Conklin RH, Mark HM. Corticosteroids and antibiotics for the treatment of fulminant hydrocarbon aspiration. JAMA 1972; 219:1434.</a></li><li><a class="nounderline abstract_t">Bergeson PS, Hales SW, Lustgarten MD, Lipow HW. Pneumatoceles following hydrocarbon ingestion. Report of three cases and review of the literature. Am J Dis Child 1975; 129:49.</a></li><li><a class="nounderline abstract_t">Thalhammer GH, Eber E, Zach MS. Pneumonitis and pneumatoceles following accidental hydrocarbon aspiration in children. Wien Klin Wochenschr 2005; 117:150.</a></li><li><a class="nounderline abstract_t">Mortiz F, de La Chapelle A, Bauer F, et al. Esmolol in the treatment of severe arrhythmia after acute trichloroethylene poisoning. Intensive Care Med 2000; 26:256.</a></li><li><a class="nounderline abstract_t">Anas N, Namasonthi V, Ginsburg CM. Criteria for hospitalizing children who have ingested products containing hydrocarbons. JAMA 1981; 246:840.</a></li><li><a class="nounderline abstract_t">Klein BL, Simon JE. Hydrocarbon poisonings. Pediatr Clin North Am 1986; 33:411.</a></li><li><a class="nounderline abstract_t">Schneider MS, Mani MM, Masters FW. Gasoline-induced contact burns. J Burn Care Rehabil 1991; 12:140.</a></li><li><a class="nounderline abstract_t">Shusterman EM, Williams SR, Childers BJ. Soft tissue injection of hydrocarbons: a case report and review of the literature. J Emerg Med 1999; 17:63.</a></li><li><a class="nounderline abstract_t">Bourget DM, Perrone J. High-pressure decisions: recognition and management of uncommon hand injuries. J Med Toxicol 2011; 7:162.</a></li><li><a class="nounderline abstract_t">Amsdell SL, Hammert WC. High-pressure injection injuries in the hand: current treatment concepts. Plast Reconstr Surg 2013; 132:586e.</a></li><li><a class="nounderline abstract_t">Gummin DD, Mowry JB, Beuhler MC, et al. 2019 Annual Report of the American Association of Poison Control Centers' National Poison Data System (NPDS): 37th Annual Report. Clin Toxicol (Phila) 2020; 58:1360.</a></li><li><a class="nounderline abstract_t">Gurwitz D, Kattan M, Levison H, Culham JA. Pulmonary function abnormalities in asymptomatic children after hydrocarbon pneumonitis. Pediatrics 1978; 62:789.</a></li><li class="breakAll">Barone S. Child-resistant packaging. Consumer product safety review 2002; 6:3. www.cpsc.gov/cpscpub/pubs/cpsr_nws23.pdf (Accessed on August 05, 2009).</li><li><a class="nounderline abstract_t">Van Gorcum TF, Hunault CC, Van Zoelen GA, et al. Lamp oil poisoning: did the European guideline reduce the number and severity of intoxications? Clin Toxicol (Phila) 2009; 47:29.</a></li></ol></div><div id="topicVersionRevision">Topic 128119 Version 14.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24911841" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : Hydrocarbon toxicity: A review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3320909" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : Hydrocarbon poisoning--current management.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3320909" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : Hydrocarbon poisoning--current management.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10639545" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : Ingestion of toxic substances by children.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15641639" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : Position paper: gastric lavage.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23418938" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : Position paper update: gastric lavage for gastrointestinal decontamination.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23418938" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : Position paper update: gastric lavage for gastrointestinal decontamination.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3082595" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : Management of kerosene-induced pulmonary injury.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30236893" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : Surfactant for the management of pediatric hydrocarbon ingestion.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21624880" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : Early administration of intratracheal surfactant (calfactant) after hydrocarbon aspiration.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8020296" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : Treatment of hydrocarbon pneumonitis. High frequency jet ventilation as an alternative to extracorporeal membrane oxygenation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17417121" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : High-frequency percussive ventilation in a pediatric patient with hydrocarbon aspiration.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : The use of high frequency oscillatory ventilation in hydrocarbon pneumonitis</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8699548" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : Benefits of extracorporeal membrane oxygenation for hydrocarbon pneumonitis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7089655" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : Hydrocarbon poisoning in children.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/4557603" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : Adrenocorticosteroid treatment of hydrocarbon pneumonia in children--a cooperative study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/5066898" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : Corticosteroids and antibiotics for the treatment of fulminant hydrocarbon aspiration.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1130343" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : Pneumatoceles following hydrocarbon ingestion. Report of three cases and review of the literature.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15847196" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : Pneumonitis and pneumatoceles following accidental hydrocarbon aspiration in children.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10784325" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : Esmolol in the treatment of severe arrhythmia after acute trichloroethylene poisoning.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7253158" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : Criteria for hospitalizing children who have ingested products containing hydrocarbons.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2870464" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : Hydrocarbon poisonings.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2050721" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : Gasoline-induced contact burns.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9950390" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : Soft tissue injection of hydrocarbons: a case report and review of the literature.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21069491" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : High-pressure decisions: recognition and management of uncommon hand injuries.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24076706" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : High-pressure injection injuries in the hand: current treatment concepts.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33305966" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : 2019 Annual Report of the American Association of Poison Control Centers' National Poison Data System (NPDS): 37th Annual Report.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/724322" id="rid27" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>28 : Pulmonary function abnormalities in asymptomatic children after hydrocarbon pneumonitis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/724322" id="rid28" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>29 : Pulmonary function abnormalities in asymptomatic children after hydrocarbon pneumonitis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19153851" id="rid29" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>30 : Lamp oil poisoning: did the European guideline reduce the number and severity of intoxications?</p>
</a>
</div>
</div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
